Personensuche
Personensuche
Es wurde 1 Person gefunden.
E-Mail
Funktionen
-
Oberarzt/-ärztin, Klinik für Allgemein-, Viszeral- und Transplantationschirugie
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Three-Dimensional Computed Tomography-Magnetic Resonance Cholangiopancreatography Imaging Fusion for Computer-Assisted Surgery Planning in Full Graft Living Donor Liver Transplant : A Single Centre ExperienceIn: Experimental and Clinical Transplantation, Jg. 23, 2025, Nr. 1, S. 29 – 42DOI (Open Access)
-
Portal and Hepatic Venous Territorial Mapping in Healthy Human Livers : Virtual Three-Dimensional Computed Tomography Size-Shape-Topography StudyIn: Experimental and Clinical Transplantation, Jg. 20, 2022, Nr. 9, S. 826 – 834DOI (Open Access)
-
Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkersIn: Transplant Immunology, Jg. 69, 2021, 101448
-
Posttraumatic stress disorder, quality of life, and the subjective experience in liver transplant recipientsIn: Progress in Transplantation, Jg. 28, 2018, Nr. 1, S. 70 – 76DOI, Online Volltext (Open Access)
-
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin ProphylaxisIn: Annals of Transplantation, Jg. 23, 2018, S. 789 – 801DOI (Open Access)
-
Effectiveness of subcutaneous & intravenous Hepatitis B immunoglobulin to prevent reinfection after liver transplantation : Long-term results from an international multicenter non-interventional studyIn: Transplant International, Jg. 30, 2017, Nr. S2, Special Issue: Abstracts of the 18th Congress of the European Society for Organ Transplantation, 24‐27 September 2017, Barcelona, Spain, S. 40
-
Feasibility and acceptability of an alcohol addiction therapy integrated in a transplant center for patients awaiting liver transplantationIn: Alcohol and Alcoholism, Jg. 51, 2016, Nr. 1, S. 40 – 46DOI (Open Access)
-
Sirolimus use in liver transplant recipients with Hepatocellular carcinoma: A randomized, Multicenter, open-label phase 3 TrialIn: Transplantation, Jg. 100, 2016, Nr. 1, S. 116 – 125DOI (Open Access)
-
Training, work, and lifestyle of transplant physicians and surgeons in GermanyIn: Clinical Transplantation, Jg. 30, 2016, Nr. 9, S. 1046 – 1052
-
Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantationIn: Human Immunology, Jg. 76, 2015, Nr. 9, S. 631 – 635
-
Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft FailureIn: Transplantation, Jg. 99, 2015, Nr. 9, S. 1869 – 1875DOI (Open Access)
-
Risk of venous congestion in live donors of extended right liver graftIn: World Journal of Gastroenterology, Jg. 21, 2015, Nr. 19, S. 6008 – 6017DOI (Open Access)
-
ABC-Transporter Gene Polymorphisms - Risk Factor for Biliary Complications in Liver Transplant RecipientsIn: Transplantation, Jg. 98, 2014, Nr. Suppl.1, S. 751
-
Donor Specific Antibodies Against HLA Class II and C4d-Positivity : Risk Factors for Liver Allograft FibrosisIn: Transplantation, Jg. 98, 2014, Nr. Suppl. 1, S. 161 – 162
-
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivityIn: Journal of Hepatology, Jg. 60, 2014, Nr. 3, S. 590 – 598
-
Body weight may not be sufficient for reliable estimation of subcutaneous hepatitis B immunoglobulin dose requirementIn: American Journal of Transplantation, Jg. 13, 2013, Nr. 6, S. 1615 – 1616
-
Compliance and tolerability of subcutaneous hepatitis b immunoglobulin self-administration in liver transplant patients : a prospective, observational, multicenter studyIn: Annals of Transplantation, Jg. 18, 2013, Nr. 1, S. 677 – 684
-
Donor specific Anti-MHC class II antibodies negatively impact allograft survival following liver transplantationIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S71 – S72
-
Effects of mycophenolate mofetil introduction in liver transplant patients: Results from an observational, non-interventional, multicenter study (LOBSTER)In: Clinical Transplantation, Jg. 27, 2013, Nr. 3, S. 368 – 378
-
Everolimus with reduced tacrolimus in liver transplantationIn: American Journal of Transplantation, Jg. 13, 2013, Nr. 5, S. 1373 – 1374
-
Everolimus-based immunosuppression in HVC positive de novo liver transplant recipients : 24-month results of a randomised controlled trialIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S79 – S80
-
Psychosomatische Aspekte der TransplantationsmedizinIn: Psychotherapie, Psychosomatik, Medizinische Psychologie (PPmP), Jg. 63, 2013, Nr. 6, S. 238 – 249
-
Renal function at two years in liver transplant patients receiving everolimus : Results of a randomized, multicenter studyIn: American Journal of Transplantation, Jg. 13, 2013, Nr. 7, S. 1734 – 1745
-
Soluble ligands for activating natural killer receptor (NKG2D) as screening tool to predict severity of allograft fibrosis after liver transplantationIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S293
-
The "carving" liver partitioning technique for graft hepatectomy in live donor liver transplantation : a single-center experienceIn: Surgery, Jg. 153, 2013, Nr. 2, S. 189 – 199
-
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECTIn: American Journal of Transplantation, Jg. 12, 2012, Nr. 7, S. 1855 – 1865
-
Claudin-7 Expression in Hepatocellular CarcinomaIn: Transplantation Proceedings, Jg. 44, 2012, Nr. 9, S. 2737 – 2740
-
Computer-assisted surgical planning in adult-to-adult live donor liver transplantation: How much does it help? : A single center experienceIn: Transplantation, Jg. 94, 2012, Nr. 11, S. 1138 – 1144
-
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients : A randomized controlled trialIn: American Journal of Transplantation, Jg. 12, 2012, Nr. 11, S. 3008 – 3020DOI (Open Access)
-
Genetic, immunological and clinical risk factors for biliary strictures following liver transplantationIn: Liver International, Jg. 32, 2012, Nr. 8, S. 1253 – 1261
-
Optimized endoscopic treatment of ischemic-type biliary lesions after liver transplantationIn: Gastrointestinal Endoscopy, Jg. 76, 2012, Nr. 3, S. 556 – 563
-
Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in GermanyIn: AIDS Research and Treatment, 2012, S. 197501DOI (Open Access)
-
Strategies to prevent or reduce acute and chronic kidney injury in liver transplantationIn: Liver International, Jg. 32, 2012, Nr. 2, S. 179 – 188
-
Transhilar Passage in Right Graft Live Donor Liver Transplantation : Intrahilar Anatomy and Its Impact on Operative StrategyIn: American Journal of Transplantation, Jg. 12, 2012, Nr. 3, S. 718 – 727
-
"Anatomical" versus "territorial" Belonging of the middle hepatic vein: Virtual imaging and clinical repercussionsIn: Journal of Surgical Research, Jg. 166, 2011, Nr. 1, S. 146 – 155
-
Alloreactivity in Recipients Prior to and Post Living Kidney and Liver TransplantationIn: Scandinavian Journal of Immunology, Jg. 73, 2011, Nr. 4, S. 344 – 345DOI (Open Access)
-
Colorectal cancer following liver transplantationIn: International Journal of Colorectal Disease, Jg. 26, 2011, Nr. 12, S. 1629 – 1630
-
Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients : Never Too Late?In: Digestive Diseases and Sciences, Jg. 56, 2011, Nr. 1, S. 4 – 6DOI (Open Access)
-
Donor- and recipient-derived immunity in ABO incompatible living donor liver transplantationIn: Tissue Antigens, Jg. 77, 2011, Nr. 5, S. 439
-
Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra®) in liver transplantation : An open, prospective, single-arm phase III studyIn: Transplant International, Jg. 24, 2011, Nr. 5, S. 441 – 450DOI (Open Access)
-
Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulationIn: Transplant International, Jg. 24, 2011, Nr. 7, S. 666 – 675
-
Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assemblyIn: Journal of General Virology, Jg. 92, 2011, Nr. 10, S. 2237 – 2248
-
High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patientsIn: Transplant International, Jg. 24, 2011, Nr. 5, S. 425 – 432DOI (Open Access)
-
Liver Transplantation for Hepatic Metastases of Neuroendocrine Pancreatic Tumors : A Survival-Based AnalysisIn: Transplantation, Jg. 91, 2011, Nr. 5, S. 575 – 582
-
Liver transplantation with donors over the expected lifespan in the model for end-staged liver disease era : Is Mother Nature punishing us?In: Liver International, Jg. 31, 2011, Nr. 7, S. 1054 – 1061
-
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease : single center experienceIn: European Journal of Medical Research, Jg. 16, 2011, Nr. 8, S. 342 – 348DOI (Open Access)
-
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - Limitations of the 'sickest first'-conceptIn: Transplant International, Jg. 24, 2011, Nr. 1, S. 91 – 99
-
Protektive Faktoren wie Kohärenzgefühl und soziale Unterstützung beeinflussen den psychosozialen Stress vor solider OrgantransplantationIn: Psychotherapie, Psychosomatik, Medizinische Psychologie (PPmP), Jg. 61, 2011, Nr. 2, S. 97 – 97
-
814 ATP-binding cassette transporter gene polymorphisms as independent predictive factors for severe recurrent hepatitis c after liver transplantationIn: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S316
-
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaIn: BMC Cancer, Jg. 10, 2010, S. 190DOI (Open Access)
-
Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patientsIn: Transplantation, Jg. 89, 2010, Nr. 8, S. 983 – 993
-
Depression and protective factors of mental health in people with hepatitis C : A questionnaire surveyIn: International Journal of Nursing Studies, Jg. 47, 2010, Nr. 3, S. 342 – 349
-
Does Long-Term Ventilation With PEEP > or = 10mbar Influence Graft-Function in Patients Following Liver Transplantation?In: Hepato-gastroenterology Journal, Jg. 57, 2010, Nr. 101, S. 839 – 844
-
Donor/recipient algorithm for management of the middle hepatic vein in right graft live donor liver transplantationIn: American Journal of Surgery, Jg. 199, 2010, Nr. 5, S. 708 – 715
-
Established and emerging therapies for hepatocellular carcinomaIn: Minerva Medica, Jg. 101, 2010, Nr. 6, S. 405 – 418
-
Hepatic Venous Drainage: How Much Can We Learn From Imaging Studies? : Anatomic-Functional Classification Derived From Three-Dimensional Computed Tomography ReconstructionsIn: Transplantation, Jg. 89, 2010, Nr. 12, S. 1518 – 1525
-
How far can we go with positive end-expiratory pressure (PEEP) in liver transplant patients?In: Journal of Clinical Anesthesia, Jg. 22, 2010, Nr. 2, S. 104 – 109
-
Impact of a living donor liver transplant program for Hepatocellular carcinoma to the running local deceased donor liver transplant programIn: Digestive Diseases and Sciences, Jg. 55, 2010, Nr. 3, S. 872 – 873
-
Infectious Complications in Liver Transplant Recipients in the MELD EraIn: American Journal of Transplantation, Jg. 10, 2010, Nr. Suppl. 4, S. 352
-
Is positive end-expiratory pressure suitable for liver recipients with a rescue organ offer?In: Journal of Critical Care, Jg. 25, 2010, Nr. 3, S. 477 – 482
-
LOBSTER - Liver Observational Study to assess the effect of cellcept therapy on clinical outcomes in liver transplant patients : Interim results after 6 monthsIn: Transplant International, Jg. 23, 2010, Nr. Suppl. 2, S. 6
-
Liver Transplantation in cirrhotic patients with hepatocellular carcinoma and concomitant HIV infection : Two more reasons to accept or to deny?In: Transplantation, Jg. 90, 2010, Nr. 1, S. 97 – 98
-
Liver transplantation for polycystic liver disease : The University Hospital Essen ExperienceIn: Transplant International, Jg. 23, 2010, Nr. Suppl. 2, S. 29
-
Long-term outcomes after orthotopic liver transplantation in HIV-infected patients with end-stage liver diseaseIn: Transplant International, Jg. 23, 2010, Nr. Suppl. 2, S. 30
-
Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomasIn: Liver International, Jg. 30, 2010, Nr. 7, S. 996 – 1002
-
Neurologic complications in adult living donor liver transplant patients : An underestimated factor?In: Journal of Neurology, Jg. 257, 2010, Nr. 2, S. 253 – 258DOI (Open Access)
-
Psychosomatische Aspekte der LeberlebendspendeIn: Der Chirurg, Jg. 81, 2010, Nr. 9, S. 820 – 825
-
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionIn: Molecular Cancer, Jg. 9, 2010, 227DOI (Open Access)
-
Surgical treatment of Klatskin tumor : Liver resection versus transplantationIn: Hepato-gastroenterology Journal, Jg. 57, 2010, Nr. 104, S. 1337 – 1340
-
Tako-Tsubo syndrome as a rare cause of cardiac failure in liver transplantationIn: Liver International, Jg. 30, 2010, Nr. 1, S. 159 – 160
-
Liberal policy in living donor liver transplantation for hepatocellular carcinoma : Lessons learnedIn: Digestive Diseases and Sciences, Jg. 54, 2009, Nr. 2, S. 377 – 384
-
Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis : Which is the best oncological approach?In: Digestive Diseases and Sciences, Jg. 54, 2009, Nr. 10, S. 2264 – 2273
-
Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinomaIn: Liver International, Jg. 29, 2009, Nr. 3, S. 399 – 405
-
When the heart kills the liver : acute liver failure in congestive heart failureIn: European Journal of Medical Research volume, Jg. 14, 2009, Nr. 12, S. 541 – 546(Open Access)
-
"Preemptive" Live Donor Liver Transplantation for Fibrolamellar Hepatocellular Carcinoma : A Case ReportIn: Transplantation Proceedings, Jg. 40, 2008, Nr. 10, S. 3806 – 3807
-
Liver Transplantation as a Primary Indication for Intrahepatic Cholangiocarcinoma : A Single-Center ExperienceIn: Transplantation Proceedings, Jg. 40, 2008, Nr. 9, S. 3194 – 3195
-
Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels : is an expansion of the listing criteria justified?In: Hepato-gastroenterology, Jg. 55, 2008, Nr. 86-87, S. 1671 – 1677
-
Living Donor Liver Transplantation for Hepatocellular Carcinoma in Patients Exceeding the UCSF CriteriaIn: Transplantation Proceedings, Jg. 40, 2008, Nr. 9, S. 3185 – 3188
-
Pulmonary nodules at risk in patients undergoing liver transplantation for hepatocellular carcinomaIn: Transplant International, Jg. 21, 2008, Nr. 9, S. 850 – 856DOI (Open Access)
-
Role of Osteopontin and CD44s Expression for Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation or ResectionIn: Transplantation Proceedings, Jg. 40, 2008, Nr. 9, S. 3182 – 3184
-
Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis : Results and ethical issuesIn: European Surgical Research, Jg. 40, 2008, Nr. 1, S. 7 – 13
-
Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantationIn: Alimentary Pharmacology and Therapeutics, Jg. 26, 2007, Nr. 2, S. 291 – 303DOI (Open Access)
-
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitisIn: World Journal of Gastroenterology, Jg. 12, 2006, Nr. 5, S. 697 – 702DOI (Open Access)
-
Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinomaIn: International Journal of Cancer, Jg. 119, 2006, Nr. 12, S. 2851 – 2860DOI (Open Access)
-
Liver transplantation for patients with metastatic endocrine tumors : Single-center experience with 15 patientsIn: Liver Transplantation, Jg. 12, 2006, Nr. 7, S. 1089 – 1096DOI (Open Access)
-
Stabilisierung der Abstinenz durch Psychoedukation für alkoholabhängige Patienten vor LebertransplantationIn: Zeitschrift für Psychosomatische Medizin und Psychotherapie, Jg. 52, 2006, Nr. 4, S. 341 – 357
-
Ein manualisiertes Gruppentherapiekonzept für alkoholabhängige Patienten vor der LebertransplantationIn: Zeitschrift für Psychosomatische Medizin und Psychotherapie, Jg. 52, 2005, Nr. 3, S. 243 – 258
-
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection : Preliminary results of an open prospective studyIn: Transplantation Proceedings, Jg. 36, 2004, Nr. 5, S. 1489 – 1491
-
Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infectionIn: Transplantation Proceedings, Jg. 35, 2003, Nr. 6, S. 2080 – 2081
-
Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantationIn: Clinical Transplantation, Jg. 17, 2003, Nr. 6, S. 554 – 559
-
Decreased expression of tumor suppressor microrna-101 promotes human hepatocellular carcinoma progression through upregulation of polycomb group protein enhancer of zeste homolog 2In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S134
-
Everolimus with early reduction of elimination of tacrolimus : 12 month results of a randomized, controlled study in 719DE novo liver transplant recipientsIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S551 – S552
-
Impact of Everolimus-Based Immunosuppression on Efficacy, Safety and Progression of Fibrosis in Hepatitis C Virus Positive De Novo Liver Transplant Recipients : 12 Months Results from H2304 StudyIn: Transplantation. Philadelphia: Lippincott Williams & Wilkins, Jg. 94, 2012, S. 8
-
Increased levels of soluble ligands of the activating natural killer receptor (NKG2D) are independent risk factors for advanced fibrosis in liver transplant recipientsIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S308
-
Soluble Ligands for Activating Natural Killer Receptor (NKG2D) Are Biomarkers for Progression of Hepatic Fibrosis after Liver TransplantationIn: Transplantation. Philadelphia: Lippincott Williams & Wilkins, Jg. 94, 2012, Nr. 10S, S. 427
-
ABCG5/8 and ABCB1 Polymorphisms as Risk Factors for advanced Fibrosis following liver Transplantation
5th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics. September 4-7, 2011. Glasgow, United Kingdom,In: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 2, S. 30 -
Altered Cytokines Pattern in Patients with Ischemic Type Biliary Lesions following liver Transplantation
15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics. September 4-7, 2011. Glasgow, United Kingdom,In: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 2, S. 158 -
Biliary strictures following liver transplantation : Role of chemokine receptor polymorphis, donor-specific anti-HLA antibodies and serum cytokine profile
20th Annual Congress of the German Transplantation Society. Regensburg, Germany. October 6-8, 2011,In: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 3, S. 20 -
Genetic polymorphisms of ABCG5/8 and ABCB1 and their impact after liver transplantationIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S224
-
Impact of ATP-Binding Cassette Transporter Polymorphisms on Fibrosis Progression in Hepatitis C aftrer liver Transplantation
20th Annual Congress of the German Transplantation Society. Regensburg, Germany. October 6-8, 2011,In: Transplant International, Jg. 24, 2011, Nr. Suppl. 3, S. 57 – 58 -
Polymorphisms of fractalkine receptor and immunologic risk factors for anastomosis stenosis after liver transplantationIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S279
-
Polymorphisms of fractalkine receptor and immunologic risk factors for anastomosis stenosis after liver transplantationIn: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 2, S. 12
-
The putative tumor suppressor microrna-101 negatively regulates the polycomb group protein enhancer of zeste homolog 2 (EZH2) in human hepatocellular carcinoma cells
46th annual meeting of the European Association for the Study of the Liver ; Berlin, 30 March-3 April 2011,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S110 -
134 Chemokine receptor and atp-binding cassette transporter gene polymorphisms as risk factors for anastomotic and non-anastomotic strictures development following liver transplantation
45th annual meeting of the European Association for the Study of the Liver (EASL) 14-18 April 2010 • Vienna, Austria,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S61 -
862 Decreased expression of MIR-199a-5p contributes to increased cell invasion by functional deregulation of DDR1 activity in hepatocellular carcinoma
45th annual meeting of the European Association for the Study of the Liver (EASL) 14-18 April 2010 • Vienna, Austria,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S336 -
Effiacy and safety of subcutaneous human HBV-immunoglobulin (ZUTECTRA (R)) in liver transplantation : an open, prospective, single-arm phase III study
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International. Lausanne: Frontiers Media, Jg. 23, 2010, Nr. Suppl. 2, S. 18 -
Hepatitis B Virus specific immune transfer in abo incompatible living donor liver transplantation
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International. Lausanne: Frontiers Media, Jg. 23, 2010, Nr. Suppl. 2, S. 29 -
Hepatitis C liver transplantation recipients with ABCG8 and MDR 1 polymorphisms have a significantly higher prevalence of advanced fibrosis
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International. Lausanne: Frontiers Media, Jg. 23, 2010, Nr. Suppl. 2, S. 27 – 28 -
Non-invasive assessment of severe graft fibrosis and inflammation in patients transplanted for Non-HCV related liver diseases
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International. Lausanne: Frontiers Media, Jg. 23, 2010, Nr. Suppl. 2, S. 58 – 59 -
Single nucleotide polymorphisms of chemokine receptors and ATP-binding cassette transporter and risk of biliary strictures after liver transplantation
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International. Lausanne: Frontiers Media, Jg. 23, 2010, Nr. Suppl. 2, S. 52 – 53 -
Transient elastography and development of a non-invasive multiparameter score for assessment of allograft fibrosis in liver transplant patientsIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S159